Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
APA Corp
APA
$14.8B
| $296K | ﹤0.01% |
+20,834
| New | +$243K |
|
1977
Mastech Digital
MHH
$89.7M
| $296K | ﹤0.01% |
18,601
-11,154
| -37% | -$201K |
|
1978
United Airlines
UAL
$36.7B
| $294K | ﹤0.01% |
+6,805
| New | +$275K |
|
|
LAND
1979
Gladstone Land Corp
LAND
$378M
| $293K | ﹤0.01% |
20,002
+9,070
| +83% | +$132K |
|
1980
PLDT
PHI
$4.18B
| $293K | ﹤0.01% |
10,512
+195
| +2% | +$5.42K |
|
|
VBIV
1981
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $293K | ﹤0.01% |
3,556
-362
| -9% | -$30.9K |
|
|
SYRS
1982
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $292K | ﹤0.01% |
2,690
-1,943
| -42% | -$177K |
|
1983
Cousins Properties
CUZ
$4.92B
| $291K | ﹤0.01% |
8,811
+1,180
| +15% | +$36.5K |
|
|
KRTX
1984
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $290K | ﹤0.01% |
+2,857
| New | +$265K |
|
1985
EverQuote
EVER
$941M
| $289K | ﹤0.01% |
7,744
-5,773
| -43% | -$218K |
|
1986
Atomera
ATOM
$178M
| $283K | ﹤0.01% |
17,567
| – | – |
|
1987
Sabre
SABR
$884M
| $282K | ﹤0.01% |
+23,793
| New | +$220K |
|
1988
Ardelyx
ARDX
$976M
| $280K | ﹤0.01% |
43,282
-128,091
| -75% | -$760K |
|
1989
Viasat
VSAT
$10.1B
| $280K | ﹤0.01% |
+8,576
| New | +$295K |
|
1990
Abeona Therapeutics
ABEO
$345M
| $278K | ﹤0.01% |
7,082
+2,580
| +57% | +$87.9K |
|
1991
Baker Hughes
BKR
$61.1B
| $278K | ﹤0.01% |
13,331
-5,144
| -28% | -$90.4K |
|
1992
Mercury Systems
MRCY
$5.36B
| $278K | ﹤0.01% |
3,177
-5,993
| -65% | -$455K |
|
1993
Principal Financial Group
PFG
$23.8B
| $278K | ﹤0.01% |
5,667
-33,467
| -86% | -$1.53M |
|
|
SRC
1994
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $278K | ﹤0.01% |
+7,009
| New | +$253K |
|
1995
BridgeBio Pharma
BBIO
$15.8B
| $277K | ﹤0.01% |
3,901
-1,848
| -32% | -$89.2K |
|
1996
SoundThinking
SSTI
$78.9M
| $275K | ﹤0.01% |
7,292
-2,527
| -26% | -$82.9K |
|
1997
POSCO
PKX
$17.8B
| $274K | ﹤0.01% |
4,395
-733
| -14% | -$38.9K |
|
1998
Cohu
COHU
$2.44B
| $272K | ﹤0.01% |
+7,126
| New | +$194K |
|
1999
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $272K | ﹤0.01% |
15,390
-2,868
| -16% | -$50.4K |
|
2000
Edison International
EIX
$28.3B
| $271K | ﹤0.01% |
+4,384
| New | +$264K |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.